Cargando…
Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
Primary liver cancer is a common kind of digestive cancers with high malignancy, causing 745,500 deaths each year. Hepatocellular carcinoma is the major pathological type of primary liver cancer. Traditional treatment methods for patients with hepatocellular carcinoma have shown poor efficacy in kil...
Autores principales: | Xie, Yingjun, Xiang, Yien, Sheng, Jiyao, Zhang, Dan, Yao, Xiaoxiao, Yang, Yongsheng, Zhang, Xuewen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896259/ https://www.ncbi.nlm.nih.gov/pubmed/29785403 http://dx.doi.org/10.1155/2018/8740976 |
Ejemplares similares
-
Bioinformatic Analysis of Circular RNA-Associated ceRNA Network Associated with Hepatocellular Carcinoma
por: Wu, Jiacheng, et al.
Publicado: (2019) -
Immunotherapy for hepatocellular carcinoma: Current and future
por: Johnston, Michael P, et al.
Publicado: (2019) -
Analysis of Transcription Factor-Related Regulatory Networks Based on Bioinformatics Analysis and Validation in Hepatocellular Carcinoma
por: Liu, Shui, et al.
Publicado: (2018) -
MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway
por: Xie, Yingjun, et al.
Publicado: (2019) -
Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects
por: Liu, Zhuoyan, et al.
Publicado: (2021)